Pelvic lymph node mapping in prostate cancer: examining the impact of PSMA PET/CT on radiotherapy decision-making in patients with node-positive disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Pelvic lymph node mapping in prostate cancer: examining the impact of PSMA PET/CT on radiotherapy decision-making in patients with node-positive disease ; volume:24 ; number:1 ; day:29 ; month:7 ; year:2024 ; pages:1-7 ; date:12.2024
Cancer imaging ; 24, Heft 1 (29.7.2024), 1-7, 12.2024
- Creator
-
Furman, Ben
Falick Michaeli, Tal
Den, Robert
Ben Haim, Simona
Popovtzer, Aron
Wygoda, Marc
Blumenfeld, Philip
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40644-024-00742-3
- URN
-
urn:nbn:de:101:1-2410132117463.114136831122
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Furman, Ben
- Falick Michaeli, Tal
- Den, Robert
- Ben Haim, Simona
- Popovtzer, Aron
- Wygoda, Marc
- Blumenfeld, Philip
- SpringerLink (Online service)
Other Objects (12)
The prognostic significance of lymph node size in node-positive colon cancer
Low rate of lymphedema after extended pelvic lymphadenectomy followed by pelvic irradiation of node-positive prostate cancer
A tailored approach in lymph node-positive perihilar cholangiocarcinoma
Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysis
Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial -
Freely available artificial intelligence for pelvic lymph node metastases in PSMA PET-CT that performs on par with nuclear medicine physicians
Different outcome in node-positive breast cancer patients found by axillary ultrasound or sentinel node procedure
Risk for Pelvic Metastasis and Role of Pelvic Lymphadenectomy in Node-Positive Vulvar Cancer-Results from the AGO-VOP.2 QS Vulva Study
Risk for pelvic metastasis and role of pelvic lymphadenectomy in node-positive vulvar cancer-results from the AGO-VOP.2 QS vulva study
Targeting and limiting surgery for patients with node-positive breast cancer
Clinical Outcome of Patients with Lymph Node-Positive Prostate Cancer following Radical Prostatectomy and Extended Sentinel Lymph Node Dissection
Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer
The prognostic significance of lymph node size in node-positive colon cancer
Low rate of lymphedema after extended pelvic lymphadenectomy followed by pelvic irradiation of node-positive prostate cancer
A tailored approach in lymph node-positive perihilar cholangiocarcinoma
Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysis
Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial -
Freely available artificial intelligence for pelvic lymph node metastases in PSMA PET-CT that performs on par with nuclear medicine physicians
Different outcome in node-positive breast cancer patients found by axillary ultrasound or sentinel node procedure
Risk for Pelvic Metastasis and Role of Pelvic Lymphadenectomy in Node-Positive Vulvar Cancer-Results from the AGO-VOP.2 QS Vulva Study
Risk for pelvic metastasis and role of pelvic lymphadenectomy in node-positive vulvar cancer-results from the AGO-VOP.2 QS vulva study
Targeting and limiting surgery for patients with node-positive breast cancer
Clinical Outcome of Patients with Lymph Node-Positive Prostate Cancer following Radical Prostatectomy and Extended Sentinel Lymph Node Dissection
Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer
The prognostic significance of lymph node size in node-positive colon cancer
Low rate of lymphedema after extended pelvic lymphadenectomy followed by pelvic irradiation of node-positive prostate cancer
A tailored approach in lymph node-positive perihilar cholangiocarcinoma
Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysis
Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial -
Freely available artificial intelligence for pelvic lymph node metastases in PSMA PET-CT that performs on par with nuclear medicine physicians
Different outcome in node-positive breast cancer patients found by axillary ultrasound or sentinel node procedure
Risk for Pelvic Metastasis and Role of Pelvic Lymphadenectomy in Node-Positive Vulvar Cancer-Results from the AGO-VOP.2 QS Vulva Study
Risk for pelvic metastasis and role of pelvic lymphadenectomy in node-positive vulvar cancer-results from the AGO-VOP.2 QS vulva study
Targeting and limiting surgery for patients with node-positive breast cancer
Clinical Outcome of Patients with Lymph Node-Positive Prostate Cancer following Radical Prostatectomy and Extended Sentinel Lymph Node Dissection